Trials / Completed
CompletedNCT03404284
Assessment of Family Planning and Immunization Service Integration in Malawi
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 43 (actual)
- Sponsor
- Jhpiego · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- —
Summary
This is a mixed methods process evaluation of a programmatic intervention to integrate family planning and immunization services at health facilities and through outreach services in Dowa and Ntchisi districts of Malawi. The study involved qualitative methods (in depth interviews and focus group discussions with service providers, mothers and fathers of infants \<1 year, and supervisors and program managers) as well as secondary analysis of service statistics for family planning and immunization services and of supervision reports.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Family planning and infant immunization service integration | The approach involved integration of services through health surveillance assistant (HSA) outreach as well as through the health facility platform. The HSAs provided door to door FP services in their designated communities as well as provided integrated FP and Immunisation services at village clinics and outreach sessions. At outreach sessions, mothers were offered both routine infant immunization and family planning services (pills, condoms, injectables plus referrals for other methods). At health facilities, mothers who sought routine infant immunization services were offered same-day family planning services and those who seek family planning services are also screened for infant immunization schedule completion / need for infant immunization services. HSAs and health facility providers were trained on FP-immunization service integration and were monitored through regular supportive supervision visits. |
Timeline
- Start date
- 2016-06-01
- Primary completion
- 2017-09-01
- Completion
- 2017-09-01
- First posted
- 2018-01-19
- Last updated
- 2018-01-19
Source: ClinicalTrials.gov record NCT03404284. Inclusion in this directory is not an endorsement.